Glenmark Pharmaceuticals Limited

Early data on Ichnos Glenmark Innovation’s (IGI) trispecific T-cell engager ISB 2001 in multiple myeloma presented at the American Society of Clinical Oncology (ASCO) meeting has signalled “deep and d

The US Food and Drug Administration should return “pretty soon” to inspect Glenmark’s key injectables manufacturing facility in Monroe, North Carolina, according to the Indian firm, which continues to

A pair of key supplementary protection certificates and their underlying compound patent shielding AstraZeneca’s Forxiga (dapagliflozin) blockbuster treatment for diabetes have been invalidated by the

The UK appeals court has temporarily blocked the sale of Glenmark’s generic version of AstraZeneca’s Forxiga (dapagliflozin) blockbuster treatment for diabetes while a UK court decides whether a key p